Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Distillation of the clinical algorithm improves prognosis by multi-task deep learning in high-risk Neuroblastoma
Authors
Keywords
Neuroblastoma, Deep learning, Gene expression, Machine learning algorithms, Survival analysis, Hierarchical clustering, Prognosis, Distillation
Journal
PLoS One
Volume 13, Issue 12, Pages e0208924
Publisher
Public Library of Science (PLoS)
Online
2018-12-08
DOI
10.1371/journal.pone.0208924
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gene expression and molecular pathway activation signatures of MYCN-amplified neuroblastomas
- (2017) Ivan Petrov et al. Oncotarget
- Artificial neural network classifier predicts neuroblastoma patients’ outcome
- (2016) Davide Cangelosi et al. BMC BIOINFORMATICS
- An 18 gene expression-based score classifier predicts the clinical outcome in stage 4 neuroblastoma
- (2016) Daniela Formicola et al. Journal of Translational Medicine
- Deep learning
- (2015) Yann LeCun et al. NATURE
- Comparison of RNA-seq and microarray-based models for clinical endpoint prediction
- (2015) Wenqian Zhang et al. GENOME BIOLOGY
- HIF2A and IGF2 Expression Correlates in Human Neuroblastoma Cells and Normal Immature Sympathetic Neuroblasts
- (2015) Sofie Mohlin et al. NEOPLASIA
- Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
- (2014) A. Oberthuer et al. CLINICAL CANCER RESEARCH
- Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ system
- (2014) Thomas P. Stricker et al. Molecular Oncology
- A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the Sequencing Quality Control Consortium
- (2014) NATURE BIOTECHNOLOGY
- The genetic landscape of high-risk neuroblastoma
- (2013) Trevor J Pugh et al. NATURE GENETICS
- A Comparison of MCC and CEN Error Measures in Multi-Class Prediction
- (2012) Giuseppe Jurman et al. PLoS One
- Redefining functional MYCN gene signatures in neuroblastoma
- (2012) J. M. Shohet PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Functional MYCN signature predicts outcome of neuroblastoma irrespective of MYCN amplification
- (2012) L. J. Valentijn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
- (2011) Eva J Kantelhardt et al. BMC CANCER
- Multiple Persistent Ganglioneuromas Likely Arising From the Spontaneous Maturation of Metastatic Neuroblastoma
- (2011) Jacob Rozmus et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
- (2010) K. De Preter et al. CLINICAL CANCER RESEARCH
- Prognostic Impact of Gene Expression–Based Classification for Neuroblastoma
- (2010) André Oberthuer et al. JOURNAL OF CLINICAL ONCOLOGY
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- (2010) NATURE BIOTECHNOLOGY
- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study
- (2009) Joëlle Vermeulen et al. LANCET ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search